Following on from our webinar ‘The Gut Microbiome and Probiotics’ we’ve pulled together some of the key resources and references discussed within the webinar. If you missed the live webinar, you can register to watch the recording.
Guidelines/Studies/Resources
Aaseth J, Ellefsen S, Alehagen U, Sundfør TM, Alexander J. Diets and drugs for weight loss and health in obesity – An update. Biomed Pharmacother. 2021;140:111789. doi:10.1016/j.biopha.2021.111789
Barrio C, Arias-Sánchez S, Martín-Monzón I. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review. Psychoneuroendocrinology. 2022;137:105640. doi:10.1016/j.psyneuen.2021.105640
Bjarnason I, Sission G, Hayee B. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease. Inflammopharmacology. 2019;27(3):465-473. doi:10.1007/s10787-019-00595-4
Bull MJ, Plummer NT. Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas). 2014;13(6):17-22.
Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203-209.
DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm Bowel Dis. 2016;22(5):1137-1150. doi:10.1097/MIB.0000000000000750
Dodoo CC, Wang J, Basit AW, Stapleton P, Gaisford S. Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation. Int J Pharm. 2017;530(1-2):224-229. doi:10.1016/j.ijpharm.2017.07.068
Fredua-Agyeman M, Gaisford S. Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry. Benef Microbes. 2015;6(1):141-151. doi:10.3920/BM2014.0051
Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514. doi:10.1038/nrgastro.2014.66
Johns Hopkins Medicine. The Brain & Age Connection. Accessed June 11, 2025. https://www.hopkinsmedicine.org/health/wellness-and-prevention/the-brain-and-age-connection
Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K. Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol. 2023;14:1118529. Published 2023 Jan 25. doi:10.3389/fmicb.2023.1118529
Kvasnovsky CL, Bjarnason I, Donaldson AN, Sherwood RA, Papagrigoriadis S. A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease. Inflammopharmacology. Published online May 20, 2017. doi:10.1007/s10787-017-0363-y
National Institute for Health and Care Excellence. Irritable Bowel Syndrome in Adults: Diagnosis and Management of Irritable Bowel Syndrome in Primary Care. NICE Clinical Guideline; February 2008. Updated April 2017.
NHS. Guidance on probiotics. Available at: https://www.nhs.uk/conditions/probiotics/. 2022.
Rath CM, Dorrestein PC. The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes. Curr Opin Microbiol. 2012;15(2):147-154. doi:10.1016/j.mib.2011.12.009
Redondo-Useros N, Nova E, González-Zancada N, Díaz LE, Gómez-Martínez S, Marcos A. Microbiota and Lifestyle: A Special Focus on Diet. Nutrients. 2020;12(6):1776. Published 2020 Jun 15. doi:10.3390/nu12061776
Sancandi M, De Caro C, Cypaite N, et al. Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model. Front Aging Neurosci. 2023;14:986127. Published 2023 Jan 18. doi:10.3389/fnagi.2022.986127
Sánchez-Pellicer P, Navarro-Moratalla L, Núñez-Delegido E, Ruzafa-Costas B, Agüera-Santos J, Navarro-López V. Acne, Microbiome, and Probiotics: The Gut-Skin Axis. Microorganisms. 2022;10(7):1303. Published 2022 Jun 27. doi:10.3390/microorganisms10071303
Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. Published 2020 Jan 31. doi:10.3389/fendo.2020.00025
Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. Published 2018 Jun 13. doi:10.1136/bmj.k2179
Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-1240. doi:10.1136/gutjnl-2021-324598
Speakers:
Nigel Denby – Registered Dietitian
@menopause_dietitian 
@menopause_dietitian
Alison Clark – Registered Dietitian
Professor Simon Gaisford – UCL School of Pharmacy
About Symprove
Symprove is the #1 probiotic for healthcare professionals, recommended by gastroenterologists, GPs, dietitians and nutritionists. Our unique water-based probiotic clinically proven to deliver live bacteria to the colon and is proven in randomised controlled trials, with 92% of people report a difference in real-world. Get a free 12-week trial of Symprove by speaking to our team*.
*Free 12-week trial of Symprove for UK healthcare professionals who haven’t previously received one
About BDA Gastroenterology Specialist Group
The Gastroenterology Group of the British Dietetic Association is a specialist group which is open for all BDA members with a keen interest in all things gastrointestinal. We support and develop high quality evidence based dietetic practice in Gastroenterology and Hepatology, through the channels of social media, event days and resources. All whilst, promoting the benefit of a dietitian’s role in this unique specialism.
YOU MAY ALSO BE INTERESTED IN:
Nutrition, Lifestyle and Menopause
